Intracavernosal Injection
II
Description
"Intracavernosal Injection" test evaluates erectile dysfunction by injecting medication directly into the penis to trigger an erection. Doctors use this test to assess whether blood flow or nerve function is contributing to ED, especially if oral treatments have failed. The strength and duration of the erection help determine if a vascular or neurological cause is present. This test is particularly useful when ED remains unexplained. Results support targeted treatment options, including medication adjustments, further diagnostic testing, or therapeutic intervention.
Category
Sexual Function, Reproductive Function
Procedure
Invasive
Sample Type
No biological sample is needed for this test.
Units
Points
Procedure Category
Inject
Test Group
Reproductive Health Group
Test Group Description
Reproductive Health Group: Tests within this group are dedicated to evaluating various aspects of reproductive health in both men and women. These assessments provide insights into reproductive hormone levels, menstrual cycles, fertility, and reproductive organ health.
Optimal Range
For All Individuals:
Conventional Unit: Not Available
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 3–4 points
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Allergic reactions
Injection site reactions
Priapism (Prolonged and painful erection unrelated to sexual stimulation)
Key Reasons For Testing
Treatment of Erectile Dysfunction (ED): Delivers vasodilator medications like alprostadil directly into penile tissue, enhancing blood flow and facilitating erections.
Alternative to Oral Medications: Provides effective symptom relief for patients unresponsive to or intolerant of oral ED treatments.
Diagnostic Evaluation: Assesses vascular response in erectile dysfunction, aiding diagnosis and treatment planning.
Penile Rehabilitation: Maintains penile tissue health post-prostatectomy or prolonged ED, preventing fibrosis and supporting functional recovery.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Montorsi F, Adaikan G, Becher E, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572-3588.
[2] Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl. 2003;24(6 Suppl).
[3] Levine LA, Dimitriou RJ. Salvage therapy for sildenafil citrate (Viagra) nonresponders: a pilot study of the combination of sildenafil and intracavernosal alprostadil. Urology. 2000;56(3):407-410.
[4] Porst H, Sharlip ID. Standard practice in sexual medicine: intracavernous injection therapy for erectile dysfunction. J Sex Med. 2005;2(4):533-534.
[5] Govier FE, McClure RD, Weissman RM, Chen AA, Heaton JP. How reliable are patient-reported erectile function rates post intracavernous injection therapy? J Urol. 1993;149(1):126-129.
[6] Carson CC. Injections for impotence. Urol Clin North Am. 1995;22(4):841-849.
[7] Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, Harris C. Intracavernous self-injection for erectile dysfunction: a long-term prospective study. J Urol. 1989;142(6):1441-1444.
[8] Shabsigh R, Fishman IJ, Schumann GB. Intracavernous injection therapy for erectile dysfunction: diagnostic and therapeutic applications. Am J Med Sci. 1992;304(5):347-354.
[9] Porst H. Current status of the intracavernous injection of vasodilators in erectile failure: combined intracavernous injection and oral pharmacotherapy. Urol Int. 2000;65(2):78-86.
[10] Hellstrom WJ, Sikka SC. Pharmacologic treatment of erectile dysfunction. World J Urol. 1997;15(1):30-37.
[11] Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137(5):829-836.
[12] Montorsi F, Salonia A, Deho F, Briganti A. Pharmacological management of erectile dysfunction. BJU Int. 2003;91(5):446-454.
[13] Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Erectile dysfunction diagnosis and pharmacotherapy. Urology. 1996;48(3):335-340.